Therapeutic microbiology: characterization of Bifidobacterium strains for the treatment of enteric disorders in newborns.

Several studies support the use of probiotics for the treatment of minor gastrointestinal problems in infants. Positive effects on newborn colics have been evidenced after administration of Lactobacillus strains, whereas no studies have been reported regarding the use of bifidobacteria for this purpose. This work was therefore aimed at the characterization of Bifidobacterium strains capable of inhibiting the growth of pathogens typical of the infant gastro-intestinal tract and of coliforms isolated from colic newborns. Among the 46 Bifidobacterium strains considered, 16 showed high antimicrobial activity against potential pathogens; these strains were further characterized from a taxonomic point of view, for the presence and transferability of antibiotic resistances, for citotoxic effects and adhesion to non tumorigenic gut epithelium cell lines. Moreover, their ability to stimulate gut health by increasing the metabolic activity and the immune response of epithelial cells was also studied. The examination of all these features allowed to identify 3 B. breve strains and a B. longum subsp. longum strain as potential probiotics for the treatments of enteric disorders in newborns such as infantile colics. The formulation of a synbiotic product with an appropriate prebiotic fiber capable of supporting the growth of the selected Bifidobacterium strains was also considered in this study. In this respect the ability of the 4 selected Bifidobacterium strains to use as the sole carbon source and energy source different polisaccharide fibers was investigated The last phase of the work has been dedicated to the evaluation of the gut microbial diversity in newborns whose mothers has been subjected to antibiotic therapy a few hours before the delivery because of a Streptococcus type B infection. These newborns can represent a possible target for the probiotic strains selected in this work.

Biomaterials for Clinical Application in Endodontics

Endodontic therapy consists in the management of several tissues such as pulp tissue, periodontal tissue, periapical bone and dentine. These tissues are often contaminated by blood, periapical exudates and biological fluids. An ideal orthograde or retrograde filling material should be non toxic, noncarcinogenic, nongenotoxic, biocompatible with the host tissues, insoluble in tissue fluids, and dimensionally stable. Calcium-silicate MTA based cements own many of these ideal characteristics, but the long setting time, the non-easy handling and the lack of mechanical properties at early times are few drawbacks which may complicate the clinical application. The aim of this study was to investigate the chemical, physical and biological properties of calcium-silicate MTA cements in order to improve the mechanical properties and the handling keeping the biological characteristics unchanged. Chemical and physical properties such as setting time, solubility, water-uptake, ion release, sealing ability were investigated according the ISO and ADA specifications. The bioactivity (ability to produce apatite nano-sferulities) of MTA cements were evaluated using ESEM/EDX, micro-Raman and ATR/FTIR spettroscopy.